Bendamustine hydrochloride and Jaundice - yellow skin - a phase IV clinical study of FDA data

Summary:

Jaundice - yellow skin is reported as a side effect among people who take Bendamustine hydrochloride (bendamustine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Bactrim, and have Chronic lymphocytic leukaemia.

The phase IV clinical study analyzes which people have Jaundice - yellow skin when taking Bendamustine hydrochloride. It is created by eHealthMe based on reports of 9,160 people who have side effects when taking Bendamustine hydrochloride from the FDA, and is updated regularly.

What is Bendamustine hydrochloride?

Bendamustine hydrochloride has active ingredients of bendamustine hydrochloride. eHealthMe is studying from 9,169 Bendamustine hydrochloride users. Check the latest studies of Bendamustine hydrochloride.

What is Jaundice - yellow skin?

Jaundice - yellow skin (a yellowish pigmentation of the skin) is found to be associated with 1,463 drugs and 3,045 conditions by eHealthMe. Check the latest studies of Jaundice - yellow skin.

On Jul, 11, 2026

9,160 people reported to have side effects when taking Bendamustine hydrochloride.
Among them, 24 people (0.26%) have Jaundice - yellow skin.

Could Bendamustine hydrochloride cause Jaundice - yellow skin?

Among these 24 people:

How long have people been on Bendamustine hydrochloride when they have Jaundice - yellow skin? *

What is the gender of people who have Jaundice - yellow skin when taking Bendamustine hydrochloride? *

female: 65 %
male: 35 %

What is the age of people who have Jaundice - yellow skin when taking Bendamustine hydrochloride? *

What are other drugs people take besides Bendamustine hydrochloride? *

What are other side effects people have besides Jaundice - yellow skin? *

Thrombocytopenia (decrease of platelets in blood): 9 people, 37.50%
Anaemia (lack of blood): 8 people, 33.33%
Fever: 7 people, 29.17%
Dyspnea (difficult or laboured breathing): 6 people, 25.00%
Liver Injury: 6 people, 25.00%
Confusional State: 4 people, 16.67%
Ascites (accumulation of fluid in the abdominal cavity): 4 people, 16.67%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 4 people, 16.67%
Coagulation Factor V Level Decreased: 4 people, 16.67%
Electrocardiogram St Segment Depression: 4 people, 16.67%

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 10 people, 41.67%
Lymphoma (cancer that begins in immune system cells): 9 people, 37.50%
Anaemia (lack of blood): 4 people, 16.67%
Sedation: 4 people, 16.67%
Infection: 4 people, 16.67%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 8.33%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 8.33%
Dyslipidaemia (abnormal amount of lipids): 2 people, 8.33%
Hodgkin's Lymphoma (cancer originating from white blood cells): 2 people, 8.33%
Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Bendamustine hydrochloride and have Jaundice - yellow skin?

- Check whether Jaundice - yellow skin is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bendamustine hydrochloride:

Bendamustine hydrochloride (9,169 reports)

Browse all side effects of Bendamustine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Jaundice - yellow skin:

Jaundice - yellow skin (1,463 drugs)

Browse all the conditions that are associated with Jaundice - yellow skin:

Jaundice - yellow skin (3,045 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bendamustine hydrochloride (the active ingredients of Bendamustine hydrochloride) and Bendamustine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.